Table 1.
Susceptibility of Salmonella , Shigella sp and diarrheagenic Escherichia coli isolated from stools of patients with acute diarrhea, in Madagascar
| |
Salmonella sp (n = 84)
|
Shigella sp
(n = 164) |
Diarrheagenic
E. coli
(n = 195) |
||||||
|---|---|---|---|---|---|---|---|---|---|
|
Antimicrobial |
Resistant |
Intermediate |
Susceptible |
Resistant |
Intermediate |
Susceptible |
Resistant |
Intermediate |
Susceptible |
| N (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
| Amoxicillin |
30 (35.7) |
0 (0.0) |
54 (64.3) |
103 (62.8) |
0 (0.0) |
61 (37.2) |
160 (82.1) |
0 (0.0) |
35 (17.9) |
| Amoxicillin/Clavulanic acid |
2 (2.3) |
3 (3.6) |
79 (94.1) |
12 (7.3) |
40 (24.4) |
112 (68.3) |
2 (1.0) |
21 (10.8) |
172 (88.2) |
| Ticarcillin |
30 (35.7) |
0 (0.0) |
54 (64.3) |
102 (62.2) |
1 (0.6) |
61 (37.2) |
161 (82.6) |
0 (0.0) |
34 (17.4) |
| Cephalothin |
2 (2.3) |
3 (3.6) |
79 (94.1) |
14 (8.5) |
37 (22.5) |
113 (69) |
6 (3.1) |
11 (5.6) |
178 (91.3) |
| Cefotaxime |
1 (1.2) |
0 (0.0) |
83 (98.8) |
0 (0.0) |
0 (0.0) |
164 (100) |
6 (3.1) |
0 (0.0) |
189 (96.9) |
| Ceftazidime |
1 (1.2) |
0 (0.0) |
83 (98.8) |
0 (0.0) |
0 (0.0) |
164 (100) |
3 (1.5) |
3 (1.5) |
189 (96.9) |
| Cefoxitin |
0 (0.0) |
0 (0.0) |
84 (100) |
0 (0.0) |
0 (0.0) |
164 (100) |
0 (0.0) |
1 (0.5) |
194 (99.5) |
| Gentamicin |
0 (0.0) |
0 (0.0) |
84 (100) |
0 (0.0) |
0 (0.0) |
164 (100) |
2 (1.0) |
0 (0.0) |
193 (99.0) |
| Nalidixic acid |
1 (1.2) |
2 (2.3) |
81 (96.5) |
1 (0.7) |
0 (0.0) |
163 (99.3) |
21 (10.8) |
0 (0.0) |
174 (89.2) |
| Ciprofloxacin |
0 (0.0) |
0 (0.0) |
84 (100) |
0 (0.0) |
0 (0.0) |
164 (100) |
6 (3.1) |
0 (0.0) |
189 (96.9) |
| Trimethoprim/Sulfamethoxazole | 2 (2.3) | 0 (0.0) | 82 (97.7) | 131 (79.9) | 5 (3.0) | 28 (17.1) | 165 (84.6) | 2 (1.0) | 28 (14.4) |